FDA

FDA approved the first adrenaline-based nasal spray used to treat anaphylactic shock An epochal breakthrough in the management of severe allergic reactions has been announced by the US Food and Drug Administration (FDA). The regulatory…

Green light to market a new Alzheimer's treatment that can slow disease progression by up to 35% Alzheimer's disease: some facts about the disease Alzheimer's is the most common form of dementia that predominantly affects the elderly…